BRIEF published on 02/24/2025 at 17:50, 1 year 2 months ago Median Technologies : Présentation d'eyonis™ LCS à l'ECR 2025 Intelligence Artificielle Median Technologies Cancer Du Poumon Eyonis™ LCS ECR 2025
PRESS RELEASE published on 02/24/2025 at 17:45, 1 year 2 months ago Informations privilégiées / Autres communiqués Median Technologies présentera eyonis™ LCS, logiciel IA pour dépistage cancer poumon, à l’ECR. Validation clinique réussie. Dossiers réglementaires soumis bientôt IA Dépistage Median Technologies Cancer Du Poumon Eyonis LCS
BRIEF published on 01/31/2025 at 08:05, 1 year 3 months ago Median Technologies unveils its 2024 financial results and its 2025 outlook Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
BRIEF published on 01/31/2025 at 08:05, 1 year 3 months ago Median Technologies dévoile ses résultats financiers 2024 et ses perspectives 2025 Résultats Financiers Median Technologies Eyonis™ LCS FDA Approbation Expansion 2025
PRESS RELEASE published on 01/31/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth
PRESS RELEASE published on 01/31/2025 at 08:00, 1 year 3 months ago Informations privilégiées / Autres communiqués Median Technologies communique ses indicateurs financiers clés 2024 et perspectives 2025, incluant des avancées sur eyonis™ LCS pour le dépistage du cancer du poumon Indicateurs Financiers Median Technologies Cancer Du Poumon Eyonis LCS Perspectives 2025
BRIEF published on 01/24/2025 at 08:05, 1 year 3 months ago Median Technologies Secures Up to €47.5 Million for AI Lung Cancer Diagnostics European Investment Bank Median Technologies AI Lung Cancer Diagnostics Eyonis™ EU And US Commercialization
BRIEF published on 01/24/2025 at 08:05, 1 year 3 months ago Median Technologies lève jusqu'à 47,5 millions d'euros pour le diagnostic du cancer du poumon par l'IA Banque Européenne D'investissement Technologies Médianes Eyonis™ Diagnostic Du Cancer Du Poumon Par IA Commercialisation Dans L'UE Et Aux États-Unis
PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025 AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 3 months ago Informations privilégiées / Autres communiqués Median Technologies finalise des financements de 47,5 millions d'euros pour approuver et commercialiser eyonis™ LCS aux États-Unis et en Europe. Nouveaux prêts de la BEI et financement d'IRIS soutiennent le projet Financement IRIS Median Technologies BEI Eyonis LCS
Published on 05/08/2026 at 10:30, 1 hour 35 minutes ago Previewing the Product Logic Behind Waton’s Next AI Trading Platform
Published on 05/08/2026 at 01:50, 10 hours 15 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 11 hours 20 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 12 hours 5 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 12 hours 35 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/08/2026 at 11:45, 20 minutes ago MINISFORUM and Intel to Unveil a New Chapter of Agent NAS
Published on 05/08/2026 at 11:30, 35 minutes ago Mutares launches voluntary public tender offer for outstanding Nordic Bond 2023/2027
Published on 05/08/2026 at 11:05, 1 hour ago Hisense Unveils XR10: The Apex of Projector, Bringing Cinema Into Every Home
Published on 05/08/2026 at 11:00, 1 hour 4 minutes ago Original-Research: OHB SE (von NuWays AG): BUY
Published on 05/07/2026 at 19:15, 16 hours 50 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 16 hours 50 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 16 hours 59 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 16 hours 59 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 17 hours 5 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
